Literature DB >> 6180036

Effect of treatment of mice with sera containing gamma interferon on the course of infection with Salmonella typhimurium strain LT-2.

Z Izadkhah, A D Mandel, G Sonnenfeld.   

Abstract

Swiss/Webster mice pre-treated with gamma interferon preparations and then infected with Salmonella typhimurium showed significantly increased survival when compared to mock interferon-treated or control mice. Nude mice similarly pre-treated with gamma interferon showed similar increased survival after S. typhimurium infections. If gamma interferon treatment were delayed until the commencement of the S. typhimurium infection, no effect on mortality was observed. The increased survival of the gamma interferon-treated mice did not appear to be due to increased antibody production, more rapid clearing of bacteria from the circulation, or enhanced uptake of bacteria by phagocytic cells of the spleen, liver, or lungs. The number of viable bacteria isolated from the spleens and livers of interferon-treated mice was significantly lower over time than in organs of mock interferon-treated or untreated mice, suggesting the gamma interferon treatment may have resulted in more efficient killing of bacteria by phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6180036     DOI: 10.1089/jir.1980.1.137

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  10 in total

1.  Recombinant interferon-gamma and chemotherapy with isoniazid and rifampicin in experimental murine tuberculosis.

Authors:  M Khor; D B Lowrie; A R Coates; D A Mitchison
Journal:  Br J Exp Pathol       Date:  1986-08

2.  Genetic evidence that the yopA gene-encoded Yersinia outer membrane protein Yop1 mediates inhibition of the anti-invasive effect of interferon.

Authors:  G Bukholm; G Kapperud; M Skurnik
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

Review 3.  Animal models in interferon research: some current trends.

Authors:  H Schellekens
Journal:  Experientia       Date:  1989-06-15

4.  Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice.

Authors:  G Bukholm; B P Berdal; C Haug; M Degré
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  Modulation of infection by gamma interferon treatment following trauma.

Authors:  M J Hershman; H C Polk; J D Pietsch; R E Shields; S R Wellhausen; G Sonnenfeld
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  Modulation of Klebsiella pneumoniae infection of mice by interferon-gamma.

Authors:  M J Hershman; H C Polk; J D Pietsch; D Kuftinec; G Sonnenfeld
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

7.  Salmonella bacteremia in African patients with human immunodeficiency virus infection.

Authors:  S De Wit; H Taelman; P Van de Perre; D Rouvroy; N Clumeck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

8.  Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon.

Authors:  W C Koff; W E Fogler; J Gutterman; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

9.  Effect of human leukocyte interferon on invasiveness of Salmonella species in HEp-2 cell cultures.

Authors:  G Bukholm; M Degré
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.